for the Period Ended 30 November 2024
| Balance sheet | |
| Notes |
As at
|
Notes |
2024 |
2023 |
|
|---|---|---|---|
|
|
£ |
£ |
|
| Fixed assets | |||
| Investments: | 3 |
|
|
| Total fixed assets: |
|
|
|
| Current assets | |||
| Total assets less current liabilities: |
|
|
|
| Creditors: amounts falling due after more than one year: | 4 |
( |
( |
| Total net assets (liabilities): |
|
|
|
| Capital and reserves | |||
| Called up share capital: |
|
|
|
| Other reserves: |
|
|
|
| Profit and loss account: |
|
|
|
| Shareholders funds: |
|
|
The notes form part of these financial statements
The directors have chosen to not file a copy of the company’s profit & loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 30 November 2024
for the Period Ended 30 November 2024
| 2024 | 2023 | |
|---|---|---|
| Average number of employees during the period |
|
|
for the Period Ended 30 November 2024
Shares in subsidiary undertakings Cost at 30 November 2023 and 30 November 2024 £23,997,000 Porvair Sciences Limited - Design and manufacture of filter based disposables and instrumentation for use in the biotechnology market - England and Wales - 100% ordinary shares and voting rights. Porvair Filtration Group Limited - Sale and manufacture of porous metal and plastic materials, specialist filtration and microfiltration products and filters - England and Wales - 100% ordinary shares and voting rights. Microfiltrex Limited - Dormant - England and Wales - 100% ordinary shares and voting rights.
for the Period Ended 30 November 2024
for the Period Ended 30 November 2024